Seach Medical(IL:SEMG)
ILAÂ 281.400.00 (0.00%)
IL:SEMG
Seach Medical financials statements
ILAÂ 281.40
At close:0.00 (0.00%)
Seach Medical (SEMG) Ratios
0 Followers
Seach Medical Ratios
IL:SEMG's free cash flow for Q2 2026 was ₪8.01M. For the 2026 fiscal year, IL:SEMG's free cash flow was decreased by ₪-403.00K and operating cash flow was ₪8.42M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.49 | 3.15 | 2.77 | 2.46 | 3.15 |
| Quick Ratio | 1.72 | 1.84 | 1.53 | 1.42 | 1.86 |
| Cash Ratio | 0.29 | 0.61 | 0.40 | 0.59 | 0.85 |
| Solvency Ratio | 0.14 | 0.36 | -0.16 | 0.03 | 0.25 |
| Operating Cash Flow Ratio | 0.59 | 0.55 | 0.01 | 0.47 | -0.31 |
| Short-Term Operating Cash Flow Coverage | 2.54 | 4.18 | 0.04 | 2.99 | -0.75 |
| Net Current Asset Value | ₪ 58.70M | ₪ 49.12M | ₪ 29.31M | ₪ 29.91M | ₪ 49.85M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.13 | 0.18 | 0.17 | 0.11 |
| Debt-to-Equity Ratio | 0.19 | 0.22 | 0.30 | 0.33 | 0.17 |
| Debt-to-Capital Ratio | 0.16 | 0.18 | 0.23 | 0.25 | 0.14 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Financial Leverage Ratio | 1.56 | 1.61 | 1.69 | 1.88 | 1.49 |
| Debt Service Coverage Ratio | 1.73 | 3.41 | -0.04 | 1.10 | 0.57 |
| Interest Coverage Ratio | 7.80 | 6.29 | -2.55 | 3.63 | 21.57 |
| Debt to Market Cap | 0.07 | 0.04 | 0.10 | 0.10 | 0.09 |
| Interest Debt Per Share | 0.56 | 0.65 | 0.75 | 0.87 | 0.44 |
| Net Debt to EBITDA | 0.48 | 0.09 | 9.75 | 0.71 | -1.05 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.68% | 33.56% | 24.88% | 28.54% | 34.16% |
| EBIT Margin | 8.95% | 11.04% | -1.57% | 3.00% | 6.55% |
| EBITDA Margin | 11.52% | 12.38% | 0.86% | 6.92% | 10.97% |
| Operating Profit Margin | 8.95% | 8.41% | -4.56% | 4.15% | 13.10% |
| Pretax Profit Margin | 2.54% | 7.81% | -6.84% | -3.03% | 9.25% |
| Net Profit Margin | 0.97% | 7.88% | -6.99% | -2.54% | 7.94% |
| Continuous Operations Profit Margin | 0.22% | 7.73% | -7.90% | -3.93% | 7.76% |
| Net Income Per EBT | 38.23% | 100.78% | 102.26% | 83.87% | 85.83% |
| EBT Per EBIT | 28.34% | 92.94% | 149.93% | -73.04% | 70.63% |
| Return on Assets (ROA) | 1.10% | 9.20% | -8.03% | -2.11% | 4.16% |
| Return on Equity (ROE) | 1.71% | 14.79% | -13.56% | -3.96% | 6.22% |
| Return on Capital Employed (ROCE) | 12.67% | 12.29% | -6.52% | 4.44% | 8.63% |
| Return on Invested Capital (ROIC) | 1.06% | 11.52% | -6.05% | 4.20% | 6.52% |
| Return on Tangible Assets | 1.22% | 10.85% | -9.89% | -2.61% | 4.88% |
| Earnings Yield | 1.71% | 13.24% | -17.16% | -5.52% | 4.37% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.93 | 6.77 | 6.59 | 5.62 | 3.56 |
| Payables Turnover | 7.43 | 6.99 | 9.71 | 4.77 | 8.49 |
| Inventory Turnover | 2.21 | 2.94 | 3.54 | 2.52 | 1.31 |
| Fixed Asset Turnover | 7.67 | 7.35 | 5.37 | 4.08 | 4.42 |
| Asset Turnover | 1.13 | 1.17 | 1.15 | 0.83 | 0.52 |
| Working Capital Turnover Ratio | 2.35 | 3.15 | 3.03 | 2.44 | 1.21 |
| Cash Conversion Cycle | 161.76 | 126.04 | 120.81 | 133.14 | 338.40 |
| Days of Sales Outstanding | 46.03 | 53.92 | 55.42 | 64.96 | 102.59 |
| Days of Inventory Outstanding | 164.88 | 124.35 | 102.98 | 144.67 | 278.80 |
| Days of Payables Outstanding | 49.16 | 52.23 | 37.58 | 76.49 | 43.00 |
| Operating Cycle | 210.91 | 178.27 | 158.40 | 209.63 | 381.40 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.50 | 0.48 | 0.01 | 0.51 | -0.24 |
| Free Cash Flow Per Share | 0.47 | 0.46 | -0.02 | 0.47 | -0.30 |
| Dividend Paid and CapEx Coverage Ratio | 3.28 | 21.86 | 0.25 | 11.71 | -2.16 |
| Capital Expenditure Coverage Ratio | 15.08 | 21.86 | 0.25 | 14.08 | -4.29 |
| Operating Cash Flow Coverage Ratio | 0.99 | 0.82 | 0.01 | 0.62 | -0.56 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.09 | 0.00 | 0.13 | -0.12 |
| Free Cash Flow Yield | 17.36% | 15.22% | -1.09% | 26.17% | -8.19% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 58.65 | 7.50 | -5.83 | -18.10 | 22.88 |
| Price-to-Sales (P/S) Ratio | 0.57 | 0.59 | 0.41 | 0.46 | 1.82 |
| Price-to-Book (P/B) Ratio | 1.00 | 1.12 | 0.79 | 0.72 | 1.42 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.76 | 6.57 | -91.96 | 3.82 | -12.21 |
| Price-to-Operating Cash Flow Ratio | 5.38 | 6.27 | 272.19 | 3.55 | -15.06 |
| Price-to-Earnings Growth (PEG) Ratio | -0.66 | -0.03 | -0.03 | 0.11 | -0.40 |
| Enterprise Value Multiple | 5.42 | 4.89 | 57.11 | 7.36 | 15.51 |
| Enterprise Value | 98.03M | 103.98M | 73.85M | 68.33M | 114.61M |
| EV to EBITDA | 5.42 | 4.89 | 57.11 | 7.36 | 15.51 |
| EV to Sales | 0.62 | 0.61 | 0.49 | 0.51 | 1.70 |
| EV to Free Cash Flow | 6.32 | 6.69 | -110.89 | 4.23 | -11.44 |
| EV to Operating Cash Flow | 5.90 | 6.38 | 328.22 | 3.93 | -14.10 |
| Tangible Book Value Per Share | 2.57 | 2.37 | 1.89 | 2.07 | 2.27 |
| Shareholders’ Equity Per Share | 2.69 | 2.69 | 2.28 | 2.53 | 2.55 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.91 | 0.01 | -0.15 | -0.30 | 0.16 |
| Revenue Per Share | 4.75 | 5.05 | 4.42 | 3.94 | 1.99 |
| Net Income Per Share | 0.05 | 0.40 | -0.31 | -0.10 | 0.16 |
| Tax Burden | 0.38 | 1.01 | 1.02 | 0.84 | 0.86 |
| Interest Burden | 0.28 | 0.71 | 4.35 | -1.01 | 1.41 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 |
| SG&A to Revenue | 0.20 | 0.22 | 0.06 | 0.06 | 0.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Income Quality | 10.90 | 1.20 | -0.02 | -5.10 | -1.52 |
Currency in ILS

